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Abstract
Gastroenteritis is a common illness causing considerable morbidity and mortality worldwide. Despite improvements in
detection methods, a significant diagnostic gap still remains. Human bocavirus (HBoV)s, which are associated with
respiratory infections, have also frequently been detected in stool samples in cases of gastroenteritis, and a tentative
association between HBoVs, and in particular type-2 HBoVs, and gastroenteritis has previously been made. The aim of this
study was to determine the role of HBoVs in gastroenteritis, using archived DNA samples from the case-control Infectious
Intestinal Disease Study (IID). DNA extracted from stool samples from 2,256 cases and 2,124 controls were tested for the
presence of HBoV DNA. All samples were screened in a real time PCR pan-HBoV assay, and positive samples were then
tested in genotype 1 to 3-specific assays. HBoV was detected in 7.4% but no significantly different prevalence was observed
between cases and controls. In the genotype-specific assays 106 of the 324 HBoV-positive samples were genotyped, with
HBoV-1 predominantly found in controls whilst HBoV-2 was more frequently associated with cases of gastroenteritis
(p,0.01). A significant proportion of HBoV positives could not be typed using the type specific assays, 67% of the total
positives, and this was most likely due to low viral loads being present in the samples. However, the distribution of the
untyped HBoV strains was no different between cases and controls. In conclusion, HBoVs, including HBoV-2 do not appear
to be a significant cause of gastroenteritis in the UK population.
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Introduction
In 2005 a novel parvovirus was discovered in respiratory
secretions of young children and was termed Human Bocavirus
(HBoV-1) [1]. Other important members of the parvoviridae
family include B19 which causes fith disease and human
parvovirus 4 (Parv 4) which has not yet been associated with
a disease [2]. Parvoviruses in animals are generally associated
with systemic disease but also with respiratory and enteric
symptoms [3,4]. Since the discovery of HBoV-1 three other
HBoV genotypes have been described, HBoV-2, HBoV-3 and
HBoV-4. The association between HBoV-1 and respiratory
disease has previously been well established
[5,6,7,8,9,10,11,12,13,14,15,16,17,18,19]. Although all HBoVs
have also been detected in stool samples with prevalences
ranging from ,1% to 20%, only HBoV-2 has been reported to
be associated with symptoms of gastroenteritis [20]. Neverthe-
less, the role of HBoV2 as an aetiological agent of gastroen-
teritis has not been clearly confirmed, furthermore, to date, no
clear association between the presence of HBoV-3 and HBoV-4
and disease has been established [21,22].
Recent seroepidemiological studies indicate that exposure to
HBoVs occurs early in life and 90% of the population are
seropositive by the age of 5, although differences were reported in
the seroprevalence of type-specific antibodies to the different
HBoVs, which suggested that HBoV-1 infections are more
prevalent [23].
The Infectious Intestinal Disease Study (IID Study) was
a large case control study of gastroenteritis carried out in the
UK between 1993–1996 [24] with the aim to determine the
burden and aetiology of sporadic cases IID in the UK
population. Initially, the use of classical microbiology diagnostic
methods and electron microscopy (for virus detection) failed to
detect a potential aetiological agent or toxin in 49% of the cases
[25]. Retesting of the archived samples from this study using
molecular methods for the detection of enteric viruses, bacteria
and protozoa revealed viruses to be the most common
aetiological agents of gastroenteritis,the diagnostic gap for IID
was reduced to 25% from 49% [26]. The aim of the present
study was to evaluate the role of HBoVs in IID in the UK
population, using archived DNA samples from the matched
case-control IID-1 study [26]. In addition, the presence
specifically of HBoV-1, 2 or 3 was investigated in order to
determine any possible associations between specific HBoV
genotypes and IID.
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Materials and Methods
Samples
A total of 4,380 archived DNA from the IID study [26,27] were
tested for the presence of HBoV DNA. This archive comprised
DNA extracted from stool samples from 2,256 cases and 2,124
controls.
Pan- HBoV Detection Assay
The qPCR assay targeted the NS1 gene (Ratcliff et al.,
unpublished method, personal communication) and was per-
formed using an ABI Taqman7500. Oligonucleotide primer and
probe sequences and positions are described in table 1.
The reaction consisted of 0.1 M DDT (Invitrogen), 1X
Platinum Quantitative PCR Supermix-UDG (Invitrogen), Pan-
HBoV-F and Pan-HBoV-R primers each at a concentration of
100 mm, Pan-HBoV-NS1 probe at 10 mm concentration, ROX
25 mm (Invitrogen) 2.5 ml of template DNA and RNase free
water to a final reaction volume of 25 ml. The amplification
consisted of an initial denaturation at 95uC for 10 min, followed
by 40 cycles with denaturation at 95uC for 15 sec, annealing at
55uC for 30 sec and extension at 60uC for 45 sec.
HBoV1, 2 and 3 Genotyping qPCR Assays
HBoV-1, 2 and 3-specific primer pair and probes were designed
in house through alignment of sequence data available in
GenBank. The reaction conditions are as follows; 1X Platinum
Quantitative PCR Supermix-UDG (Invitrogen), HBoV-NS1-1F,
HBoV-1R, HBoV2-R and HBoV3R primers each at a concentra-
tion of 20 mm, the HBoV1,2 and 3 probe at 10 mm concentration,
ROX 25 mm (Invitrogen), 2.5 ml of template and RNase free
water was added to a final reaction volume of 25 ml. The
amplification conditions for the typing assay are the same as those
described in the HBoV NS1 detection assay above.
Plasmid Controls
Plasmids containing a 1773 bp and a 1737 bp region of the
NS1 encoding gene of HBoV-1 and HBoV-3 respectively were
used for assay optimisation and as controls. Control material was
kindly provided by R. Ratcliff, Adelaide, Australia.
The controls were also used in order to generate a standard
curve for use with the pan-HBoV assay in order to allow for
normalisation of the data generated including the comparison of
relative sensitivities of the different assays and for quantitation of
DNA present in each of the positive samples. The standard curve
was generated using the plasmid containing a genome segment of
the HBoV-1 and consisted of a series of 10 fold dilution containing
from 300,000 copies/ml down to 3 copies/ml. Inter- and intra-
assay reproducibility was analysed by performing replicate testing
of the standards in a single run (X11) and repeated runs (X2), and
the standard curve was also included in each assay run for quality
control and normalisation of results.
Untypable Strains
A subset of 17 samples positive in the Pan-HBoV assay but which
failed to amplify in the type-specific assays were confirmed using an
alternative method published elsewhere [28,29], and 6 were further
confirmed though direct sequencing of the amplicons obtained after
purification either from solution or agarose gels using Agencourt
AMPure (Beckman Coulter, USA) and GeneClean Spin kit
(QBiogene), respectively, following manufactures protocols.
Statistical Analysis
The chi-squared test was used in order to evaluate the
significance of differences observed between groups. For compar-
ison of median values (analysis of CT values) the Mann Witney U-
test was used. Prevalence Odds Ratio (POR=Pcases/(1-Pcases)/
Pcontrols/(1-Pcontrols)) was calculated in the total cohorts and by
age group.
Table 1. HBoV-specific oligonucleotide primers and probes (all located at the NS gene).
Primers Sequence (59-39) Nt positions reference
Pan qpcr primers
Pan-HBoV-F ATA AAG TTC CAA ACT CAT TTC CTC TTG 1994–2020 Ratcliff et al*
Pan-HBoV-R AGT GCA GWA TCC GTT TTC GTG 2079-2059 Ratcliff et al*
Pan HBoV1-F TCT CC GGC GAG TGA ACA TC 201–219 This study
Type-specific qpcr primers (anti-sense)
HBoV1-R CAT CCG GAT GAG GAG CGC 424-407 This study
HBoV2-R CTT CAG GAT GTG GTG CGC 427-410 This study
HBoV3-R CAT CCG GAT GAG GA CAC 405-392 This study
Generic PCR primers for sequencing
HBoV01.2F TAT GGC CAA GGC AAT CGT CCA AG 2091 [29]
HBoV02.2R GCC GCG TGA ACA TGA GAA ACA GA 1791 [29]
Probes
pan HBoV-NS1 6FAM-CCT TTG TCC TAC WCA TTC-MGBBNFQ 2025–2042 Ratcliff et al*
HBoV-1 6Fam- TAT CAT AGA TTG TTC AGT TCC AGT AGC-MGBBNFQ 393-372 This study
HBoV-2 6Vic- TT GGA TCA TGA GAC GTT CAG TCC C-MGBBNFQ 399-376 This study
HBoV-3 6Ned- CTG GAT CAT GGC TTG CTC GGT A-MGBBNFQ 377-351 This study
*Unpublished method, personal communication.
doi:10.1371/journal.pone.0041346.t001
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Results
Prevalence of Infection with HBoVs
A total of 7.4% of the samples tested were positive for HBoV.
No statistically significant differences were seen in the prevalence
of HBoV between cases and asymptomatic controls, POR=0.79
(Table 2). Peak HBoV infection was observed in children under
the age of 5, both in cases and controls, with significantly higher
HBoV incidence in children between 1 and 4 in asymptomatic
controls than in the cases of gastroenteritis (POR=0.6; p,0.02).
The number of HBoV positives in older age groups was too small
for meaningful statistical analysis.
Viral Load
The average CT values were 34.5 and 34.8, and the median CT
values were 36.3 and 37.4 in cases and controls respectively (see
distribution in Figure 1). The majority of HBoV-positives in both
cases and controls had copy numbers ranging between 30 and 299
copies/reaction (or between 4.56103 and 4.56104 copies/ml of
feaces). The distribution of HBoV viral loads between cases and
controls was comparable and the median CT values between cases
and controls were not significantly different (U-test; z = 0.458139,
p.0.05).
HBoV in the Presence of Other Enteric Pathogens
HBoV DNA was found in 149 (46%) samples in the absence of
other co-pathogens (Table 3). No statistically significant differences
were observed in the proportion of cases or controls in which
HBoV was found as a single organism or in the presence of one or
more pathogens in the cohort as a whole, however in the 1–4 years
of age group, HBoV in the absence of any other enteric pathogens
Table 2. Age distribution of HBoV positive samples in cases and controls of IID.
CASES CONTROLS ALLTOTAL
Age Group
(years) HBoV pos % TOTAL HBoV pos % TOTAL POR HBoV pos % TOTAL
,1 34 26.2 130 62 34.8 178 0.66514 96 31.2 308
1–4 58 12.2 476 91 18.0 506 0.633 149 15.2 982
5–9 9 6.9 131 8 6.0 134 1.16112 17 6.4 265
10–19 5 4.4 114 2 1.9 103 2.37635 7 3.2 217
20–29 7 2.4 286 2 1.1 177 2.21088 9 1.9 463
30–39 8 2.2 365 3 1.0 294 2.22699 11 1.7 659
40–49 11 4.4 249 2 0.8 240 5.70711 13 2.7 489
50–59 8 4.0 199 1 0.5 192 8.29167 9 2.3 391
60–69 5 2.9 175 3 1.7 177 1.72696 8 2.3 352
.70 4 3.1 131 1 0.8 123 3.96698 5 2.0 254
TOTAL 149 6.6 2256 175 8.2 2124 0.79109 324 7.4 4380
POR=prevalence odds ratio.
doi:10.1371/journal.pone.0041346.t002
Figure 1. HBoV detection assays, CT distribution in cases and controls.
doi:10.1371/journal.pone.0041346.g001
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was found in 29% of the cases, but in 56% of the controls
(p,0.05).
Temporal Distribution of HBoV Infections
HBoV infections were detected year round although a peak was
observed in the spring/early summer months, between April and
June 1994 (Figure 2).
Distribution of HBoV by Gender
HBoV DNA was found in 48.8% and 45.7% of female cases
and controls, respectively. The distribution of HBoV among
females and males was not significantly different from the
distribution of females and males in the entire cohort which was
53% and 47%, respectively.
Distribution of HBoV Genotypes
A total of 106 (32.7%) HBoV positives were genotyped, whilst
218 (67.3%) remained untyped after testing in the HBoV types 1,
2 or 3 specific assays (Table 4). HBoV-1 detection was found
predominantly in controls, (p,0.001) and HBoV-2 was pre-
dominantly associated with cases (p,0.01). The prevalence of
HBoV-3 was not significantly different between cases and controls.
Table 3. Distribution of HBoV-positive samples in cases and controls with or without a co-infection.
CASES CONTROLS TOTAL
Age Group Single HBoV Multiple infections Single HBoV Multiple infections Single HBoV All HBoV positives
,1 18 16 24 38 42 96
1–4 17 41 51 40 68 149
5–9 2 7 4 4 6 17
10–19 0 5 1 1 1 7
20–29 4 3 2 0 6 9
30–39 4 4 2 1 6 11
40–49 6 5 2 0 8 13
50–59 5 3 1 0 6 9
60–69 3 2 1 2 4 8
.70 2 2 0 1 2 5
TOTAL 61 88 88 87 149 324
% of total positives 40.9 59.1 50.3 49.7 46.0
doi:10.1371/journal.pone.0041346.t003
Figure 2. Temporal distribution of HBoV infections.
doi:10.1371/journal.pone.0041346.g002
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HBoV-1 and -3 were predominantly found in children (Table 4).
HBoV-2 in the absence of any other pathogen was detected in 17
(81.3%) of the cases, compared to 9 (47.4%) of the controls. In
cases, HBoV-2 was found across the age groups, although more
frequently in children ,5, whereas in controls they were found
predominantly in children ,5 with only 1 example in an adult
(Table 4). The prevalence of HBoV-2 in children,5 years old was
however not significantly different between cases and controls,
2.8% and 2.6%, respectively.
A subset of HBoV that were negative in the type 1,2 or 3-
specific assays were confirmed in an alternative pan-HBoV PCR,
and sequencing of a small number confirmed them as types 1, 2 or
3. The majority of the untyped samples (70%) had a CT value of
.37 in the screening pan-HBoV PCR, indicative of low viral loads
being present in the samples.
Discussion
This represents the largest study to date investigating the role
and distribution of HBoVs infections in community acquired
sporadic gastroenteritis and in asymptomatic controls. The
prevalence of HBoV infection in the UK population was found
to be 7.4% across all ages, with a higher percentage of the
infections occurring in children ,5 years of age (19%). However,
the prevalence of HBoV infections was comparable in cases of
gastroenteritis and in age-matched asymptomatic controls. Al-
though the presence of enteric pathogens, eg norovirus or
rotavirus, in asymptomatic individuals is well documented,
a significantly higher prevalence of the pathogen is seen in cases
than in the controls [26]. Therefore, our data suggests that HBoV
are not causally associated with gastrointestinal disease in the UK
population as a whole, nor in children. The prevalence of
detection of HBoV in stool samples in previous studies varies
widely (see summary in Table 5), but most coincide in reporting
the highest prevalence in children.
HBoV infections were detected all year round in the UK
although a tentative peak was observed in the spring/early
summer months in 1994 (between April and June). Different
seasonal patterns in the peak prevalence of HBoV have been
reported in different countries (see Table 5),
Of the 324 HBoV positive samples, 106 (32.7%) were
genotyped in the type-specific assays. HBoV-1 was found pre-
dominantly in controls (p,0.001) and the prevalence of HBoV-3
was similar in cases and controls. Both HBoV-1 and -3 were
predominantly found in children. HBoV-2 was predominantly
associated with gastroenteritis cases (p,0.01). The overall
prevalence in cases was 1.4% and 0.8% in controls, however, in
children ,5 year of age, the prevalence in cases and controls was
similar, 2.8% and 2.6%, respectively. The prevalence of HBoV-2
in children in the UK was significantly lower than that reported in
Table 4. Distribution of HBoV genotypes in cases and controls.
COHORT
Age Group
(years) HBoV-1 HBoV-1+HBoV-2 HBoV-2 HBoV-3 Untyped TOTAL
CASES ,1 1 1 9 2 21 34
1–4 3 1 8 6 40 58
5–9 1 1 7 9
10–19 2 1 2 5
20–29 2 5 7
30–39 3 5 8
40–49 2 9 11
50–59 3 5 8
.70 2 2 4
60–69 5 5
CASES Total 4 2 32 10 101 149
Percent 2.7 1.3 21.5 6.7 67.8 100.0
CONTROLS ,1 10 1 10 4 37 62
1–4 14 8 6 63 91
5–9 1 7 8
10–19 2 2
20–29 2 2
30–39 2 1 3
40–49 2 2
50–59 1 1
60–69 1 2 3
.70 1 1
CONTROLS Total 24 1 19 14 117 175
Percent 13.7 0.6 10.9 8.0 66.9 100.0
GRAND TOTAL 28 3 51 24 218 324
Percent 8.6 0.9 15.7 7.4 67.3 100.0
doi:10.1371/journal.pone.0041346.t004
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a study in Australia, in which HBoV-2 was detected in 17.2% and
8.1% of the cases and controls, respectively [22]. The findings of
the study in Australia lead to the proposal of HBoV-2 as an
important aetiological agent of infantile gastroenteritis. It is
noteworthy however, that in the Australian study, the association
of HBoV-2 with gastroenteritis was only significant when cases
with a bacterial co-pathogen were included in the analysis.
Although in the present study HBoV-2 in the absence of other
enteric pathogens was found more frequently in cases than in
controls, the small numbers found in such large study suggest that
the role of these viruses in IID, if any, is likely to be small. A lack of
correlation between HBoVs or HBoV-2 and paediatric gastroen-
teritis was also reported in several smaller studies published
elsewhere [30,31,32].
A total of 67% of the HBoV-positive samples could not be
genotyped using the genotype-specific PCR assays. The majority
of these untyped samples (70%) had CT values .37. This suggests
that failure to type may be associated with low viral loads and
differences in the relative sensitivities of the genotyping assays
compared to the detection assay. Although under experimental
conditions and using plasmid controls the sensitivities of all assays
were comparable, it is likely that when applied to true clinical
samples the sensitivity of the type-specific assays was inferior,
possibly due to as yet not identified strain variability within
genotypes. Also, a HBoV type 4-specific assay was not included in
this study, therefore, any possible HBoV4 infections would not
have been typed. Of the panel of samples that were tested in an
alternative pan-HBoV PCR, the strains typed through sequencing
were HBoV-1 (2 samples), HBoV-2 (1 sample) and HBoV-3 (3
samples). Furthermore, the distribution of untyped HBoVs was not
significantly different in cases and controls.
HBoVs in the absence of other enteric pathogens were seen in
46% of the HBoV-positive samples, and more frequently in the
controls, 50.3% vs 40.9% in cases. No significant difference in
HBoV load was observed between cases and controls, or between
the samples positive for HBoV alone or in the presence of other
pathogens. Previous studies have investigated the relationships
between viral load and disease severity [33,34,35,36,37]. In
respiratory infections significantly higher HBoV loads were seen
in samples collected from children positive for HBoV alone than in
those from children with co-infections. In respiratory infections
also, viral loads .104 were associated with disease, whereas loads
,104 were associated with asymptomatic children [33,38]. This
lead to the suggestion that higher viral loads are indicative of
a causative role of HBoV in respiratory infections [33,38].
However, Brieu et al [38] found no significant correlation between
viral load and clinical symptoms or disease severity.
In conclusion, the results obtained from investigating for the
presence of HBoV DNA in archived DNA samples from a large
and previously well described case-control study of IID suggest
that HBoV, including HBoV-2,do not appear to be a significant
cause of gastroenteritis in the UK population, and particularly in
the paediatric population. Although HBoVs are relatively frequent
across all ages, and in particular in preschool age children, they are
found just as frequently among children and adults without
symptoms of gastroenteritis.
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